
Open role
Associate Director, Business Operations
Revolution Medicines

Revolution Medicines
Posted 2026-07-16
About the role
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a…
Full JD & AI apply unlock in the Sawell app
Prefer desktop? Sign in on web
Related roles
View moreApp

Associate Director, Business Development
ShopBack
App

Associate Director Business Affairs
University of Cincinnati
App

Associate Director of Business Development
W. L. Gore & Associates
App

Associate Director, Patient Services Business Design
AbbVie
App

Associate Director, Sales, Datapoints Small Molecule Business
Ginkgo Bioworks
App

Associate Director Partnership Development, Carl H. Lindner College of Business
University of Cincinnati